pyrroles has been researched along with fibrin in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, WD; Lalich, JL; Raczniak, TJ; Shumaker, RC | 1 |
| Allen, JR; Chesney, CF; Hsu, IC | 1 |
| Butler, WH | 1 |
| Copple, BL; Ganey, PE; Hanumegowda, UM; Roth, RA; Shibuya, M; Yee, SB | 1 |
| GORMSEN, J; SIVERTSEN, U | 1 |
| Dao, LH; Guidoin, R; Roberge, C; Rouabhia, M; Shi, G; Wan, Y; Wang, Z; Zhang, Z | 1 |
| Chopp, M; Goussev, A; Lu, D; Mahmood, A; Qu, C; Zhang, ZG | 1 |
| Hong, Z; Isenberg, B; Keirstead, SA; Lee, EH; Reyes, M; Ross, JJ; Tranquillo, RT; Verfaillie, CM; Weir, EK; Willenbring, B; Zeng, L | 1 |
| Adamson, U; Antovic, A; Henriksson, P; Jörneskog, G; Lins, PE; Mobarrez, F; Santesson, P; Tehrani, S; Wallén, NH | 1 |
| Doi, M; Fukushima, H; Hamada, M; Matsui, H; Mizuno, T; Nishio, K; Shida, Y; Shima, M; Sugimoto, M; Yoshioka, A | 1 |
| Karska-Basta, I; Kubicka-Trząska, A; Romanowska-Dixon, B; Undas, A | 1 |
| Ciesla-Dul, M; Undas, A; Zolcinski, M | 1 |
| Aditya, RN; Burnouf, T; Chang, LH; Chen, CH; Chuang, EY; Huang, SC; Jheng, PR; Lu, KY; Mi, FL; Nyambat, B; Tan, SJ; Tseng, CL | 1 |
1 trial(s) available for pyrroles and fibrin
| Article | Year |
|---|---|
Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia.
Topics: Adult; Aged; Atorvastatin; Biomarkers; Blood Platelets; C-Reactive Protein; Cell-Derived Microparticles; Cross-Over Studies; Diabetes Mellitus, Type 1; Double-Blind Method; Dyslipidemias; Fibrin; Fibrinolytic Agents; Glycated Hemoglobin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Integrin beta3; Middle Aged; P-Selectin; Plasminogen Activator Inhibitor 1; Pyrroles; Sweden; Thrombin; Thromboplastin; Thrombosis; Time Factors; Treatment Outcome | 2010 |
13 other study(ies) available for pyrroles and fibrin
| Article | Year |
|---|---|
Fibrin thrombosis in monocrotaline pyrrole-induced cor pulmonale in rats.
Topics: Animals; Cardiomegaly; Endothelium; Fibrin; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Pulmonary Embolism; Pulmonary Heart Disease; Pyrroles; Pyrrolizidine Alkaloids; Rats | 1977 |
Right ventricular hypertrophy in monocrotaline pyrrole treated rats.
Topics: Animals; Blood Platelets; Blood Pressure; Capillaries; Cardiomegaly; Disease Models, Animal; Endothelium; Erythrocyte Count; Fibrin; Hematocrit; Hemoglobins; Lung; Male; Microscopy, Electron; Muscle, Smooth; Myocardium; Organ Size; Pulmonary Circulation; Pyrroles; Pyrrolizidine Alkaloids; Rats; Time Factors | 1974 |
An ultrastructural study of the pulmonary lesion induced by pyrrole derivatives of the pyrrolizidine alkaloids.
Topics: Alkaloids; Animals; Basement Membrane; Capillaries; Cell Nucleus; Collagen; Cytoplasm; Cytoplasmic Granules; Endoplasmic Reticulum; Epithelium; Fibrin; Golgi Apparatus; Heterocyclic Compounds; Lipids; Lung; Macrophages; Male; Microscopy, Electron; Pulmonary Alveoli; Pulmonary Edema; Pyrroles; Rats; Ribosomes; Time Factors | 1970 |
Endothelial cell injury and coagulation system activation during synergistic hepatotoxicity from monocrotaline and bacterial lipopolysaccharide coexposure.
Topics: Animals; Blood Coagulation; Chemical and Drug Induced Liver Injury; Drug Synergism; Endothelial Cells; Fibrin; Fibrinogen; Hemoglobins; Immunoblotting; Immunohistochemistry; Lipopolysaccharides; Male; Microscopy, Electron, Scanning; Microsomes, Liver; Monocrotaline; Poisons; Pyrroles; Rats; Rats, Sprague-Dawley | 2003 |
THE EFFECT OF SULFHYDRYLINHIBITORS AND GLYCINE DERIVATIVES ON FIBRIN POLYMERIZATION AND THE PHYSICAL STRENGTH OF FIBRIN IN PLASMA.
Topics: Amides; Anesthetics, Local; Benzoates; Blood Coagulation; Chloromercuribenzoates; Cysteine; Edetic Acid; Fibrin; Glycine; Iodoacetates; Pharmacology; Plasma; Polymerization; Pyrroles; Sulfhydryl Compounds; Thrombelastography | 1964 |
In vivo evaluation of a novel electrically conductive polypyrrole/poly(D,L-lactide) composite and polypyrrole-coated poly(D,L-lactide-co-glycolide) membranes.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Biocompatible Materials; Biodegradation, Environmental; Collagen; Electric Conductivity; Fibrin; Immunohistochemistry; Inflammation; Lactic Acid; Macrophages; Male; Materials Testing; Membranes, Artificial; Microscopy, Electron, Scanning; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polytetrafluoroethylene; Prostheses and Implants; Pyrroles; Rats; Rats, Sprague-Dawley; Sterilization; Tissue Fixation | 2004 |
Delayed thrombosis after traumatic brain injury in rats.
Topics: Animals; Atorvastatin; Blood Coagulation Factors; Brain; Brain Injuries; Disease Models, Animal; Fibrin; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Thrombosis; Male; Pyrroles; Rats; Rats, Wistar; Time Factors | 2004 |
Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells.
Topics: Animals; Animals, Newborn; Becaplermin; Calcium Channel Agonists; Calcium Channels, L-Type; Cell Differentiation; Cells, Cultured; Cytokines; Fibrin; Flow Cytometry; Gene Expression; Humans; Mice; Mice, Inbred C57BL; Multipotent Stem Cells; Myocytes, Smooth Muscle; Patch-Clamp Techniques; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Pyrroles; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Swine; Transcription Factors; Transforming Growth Factor beta | 2006 |
Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions.
Topics: Atorvastatin; Blood Platelets; Dose-Response Relationship, Drug; Fibrin; Fibrinolytic Agents; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; P-Selectin; Perfusion; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Pravastatin; Pyrroles; Regional Blood Flow; Stress, Mechanical; Thrombin; Thromboplastin; Thrombosis; Time Factors; von Willebrand Factor | 2011 |
Altered fibrin clot properties in patients with retinal vein occlusion.
Topics: C-Reactive Protein; Coronary Artery Disease; Female; Fenofibrate; Fibrin; Fibrinolysis; Heptanoic Acids; Homocysteine; Humans; Hypersensitivity, Immediate; Laser Coagulation; Lipoprotein(a); Male; Pyrroles; Retinal Vein; Retinal Vein Occlusion; Simvastatin; Tetrahydroisoquinolines; Thrombosis; Venous Thromboembolism; Venous Thrombosis | 2011 |
Effects of atorvastatin on plasma fibrin clot properties in apparently healthy individuals and patients with previous venous thromboembolism.
Topics: Atorvastatin; Biomarkers; Blood Coagulation; Blood Coagulation Tests; Case-Control Studies; Dyslipidemias; Fibrin; Fibrinolytic Agents; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Poland; Pyrroles; Treatment Outcome; Ultrasonography, Doppler, Color; Venous Thromboembolism | 2012 |
The role of spinal thrombin through protease-activated receptor 1 in hyperalgesia after neural injury.
Topics: Animals; Antithrombins; Capillary Permeability; Central Nervous System Agents; Cervical Vertebrae; Disease Models, Animal; Fibrin; Hirudins; Hyperalgesia; Injections, Spinal; Male; Pain; Pain Measurement; Peripheral Nervous System Diseases; Pyrroles; Quinazolines; Radiculopathy; Rats, Sprague-Dawley; Receptor, PAR-1; Spinal Cord | 2017 |
A bioinspired hyperthermic macrophage-based polypyrrole-polyethylenimine (Ppy-PEI) nanocomplex carrier to prevent and disrupt thrombotic fibrin clots.
Topics: Animals; Biomimetic Materials; Endocytosis; Fibrin; Humans; Hyperthermia, Induced; Infrared Rays; Macrophages; Mice; Mice, Inbred ICR; Nanoparticles; Polyethyleneimine; Polymers; Pyrroles; RAW 264.7 Cells; Reactive Oxygen Species; Temperature; Thrombosis; Tissue Distribution | 2019 |